{
  "created_at": "Fri Nov 05 11:36:40 +0000 2021",
  "id_str": "1456574263201255424",
  "full_text": "Pfizer said its Covid-19 pill was 89% effective in a study. The company plans this month to seek FDA authorization for the drug. https://t.co/3fLBRPZK8h",
  "display_text_range": [
    0,
    152
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/3fLBRPZK8h",
        "expanded_url": "https://on.wsj.com/3GU4AcD",
        "display_url": "on.wsj.com/3GU4AcD",
        "indices": [
          129,
          152
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 35,
  "favorite_count": 89,
  "possibly_sensitive": false,
  "original_created_at": "Fri Nov 05 10:49:00 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "ファイザー社は、Covid-19ピルの研究で89％の効果があったと発表しました。同社は今月中にFDAの認可を得る予定である。https://t.co/3fLBRPZK8h"
    },
    {
      "locale": "zh",
      "full_text": "辉瑞公司表示，其Covid-19药片在一项研究中的有效率为89%。该公司计划在本月为该药物寻求美国食品和药物管理局的授权。https://t.co/3fLBRPZK8h。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "輝瑞公司表示，其Covid-19藥片在一項研究中的有效率爲89%。該公司計劃在本月爲該藥物尋求美國食品和藥物管理局的授權。https://t.co/3fLBRPZK8h。"
    }
  ]
}